retatrutide blindness ⚠️ BEWARE OF SOLD ONLINE! There are many "miracle" weight loss solutions spreading on social media, but not all are safe. Retatrutide is still undergoing clinical trials and NO FDA APPROVAL Retatrutide | GLP-1R/GIPR/GCGR ligand |

Regular follow-up is essential to assess therapeutic response, monitor glycemic and cardiovascular outcomes, and manage adverse effects

You cant count on one thing, whether thats a pill, a shot, or a new diet

Purpose-built for physicians GLP-1s lower BMI, preserve kidney function for adults with diabetes post-kidney transplant Key takeaways: Adults with diabetes who underwent kidney transplantation had greater reductions in BMI and body weight if they used a GLP-1

Monitoring requires baseline and ongoing liver function tests, FIB-4 scoring for fibrosis risk, and vigilance for pancreatitis and gallbladder disease

Post-GLP-1 patients can expect significant improvement in abdominal contour, with most achieving a flatter, more proportionate midsection that reflects their weight loss achievement